Research programme: poloxamer-188 therapeutics - Maroon Biotech
Alternative Names: P-188 - Maroon BiotechLatest Information Update: 04 Nov 2017
Price :
$50 *
At a glance
- Originator University of Chicago
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Brain injuries; Burns; CNS disorders; Fever; Myocardial infarction; Reperfusion injury; Spinal cord injuries
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Brain injuries in USA
- 04 Nov 2017 No recent reports of development identified for preclinical development in Burns in USA
- 04 Nov 2017 No recent reports of development identified for preclinical development in CNS-disorders in USA